-
For today's top Money video click here - News Providers
- Associated Press
- Barron's
- bizjournals.com
- Briefing.com
- BusinessWeek
- Business Wire
- Forbes
- GlobeNewswire
- InvestorPlace
- MarketWatch
- Market Wire
- Minyanville
- Motley Fool
- MSNBC
- PRNewswire
- Thomson Reuters
- TheStreet.com
- Wall Street Journal
- News by Topic
- Companies
- Economy
- Industry
- Stock Market
- Commentary
- This Week
- Index
- MSN Money Experts
- Jim Jubak
- Jon Markman
- Liz Pulliam Weston
- MP Dunleavey
- More Experts
Pfizer's Geodon gets expanded FDA approvalNovember 20, 2009 2:15 PM ET
Article tools
NEW YORK (AP) - Pfizer Inc. said Friday the Food and Drug Administration approved Geodon as a part of a combination maintenance treatment for bipolar disorder in adults. The new approval covers use of Geodon as an adjunct to lithium or valproate. The drug is already approved as a treatment for schizophrenia and bipolar disorder. Shares of Pfizer rose 20 cents to $18.31 in afternoon trading. Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
|
E-mail this article
Print-friendly version
Discuss this article
- Data providers
- Copyright © 2010 Thomson Reuters. Click for Restrictions.
- Quotes supplied by Interactive Data Real-Time Services.